GB201403630D0 - Treatment of cystic fibrosis with alginate oligomers - Google Patents
Treatment of cystic fibrosis with alginate oligomersInfo
- Publication number
- GB201403630D0 GB201403630D0 GB201403630A GB201403630A GB201403630D0 GB 201403630 D0 GB201403630 D0 GB 201403630D0 GB 201403630 A GB201403630 A GB 201403630A GB 201403630 A GB201403630 A GB 201403630A GB 201403630 D0 GB201403630 D0 GB 201403630D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- cystic fibrosis
- alginate oligomers
- oligomers
- alginate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 title 1
- 201000003883 Cystic fibrosis Diseases 0.000 title 1
- 229940072056 alginate Drugs 0.000 title 1
- 235000010443 alginic acid Nutrition 0.000 title 1
- 229920000615 alginic acid Polymers 0.000 title 1
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201403630A GB201403630D0 (en) | 2014-02-28 | 2014-02-28 | Treatment of cystic fibrosis with alginate oligomers |
| PCT/EP2015/054207 WO2015128495A1 (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function |
| CN201580010273.7A CN106029079A (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function |
| CA2940560A CA2940560A1 (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function |
| RU2016136449A RU2016136449A (en) | 2014-02-28 | 2015-02-27 | APPLICATION OF ALGINATE OLIGOMETES IN THE TREATMENT OF MUKOVISCIDOSIS AND OTHER CONDITIONS ASSOCIATED WITH THE DISTURBED FUNCTION OF CFTR ION CHANNELS |
| AU2015222051A AU2015222051A1 (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective CFTR ion channel function |
| KR1020167026840A KR20160119259A (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function |
| JP2016554405A JP2017510563A (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other pathologies associated with defective CFTR ion channel function |
| US15/121,671 US20160361342A1 (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function |
| EP15708474.0A EP3110426A1 (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201403630A GB201403630D0 (en) | 2014-02-28 | 2014-02-28 | Treatment of cystic fibrosis with alginate oligomers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201403630D0 true GB201403630D0 (en) | 2014-04-16 |
Family
ID=50490631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB201403630A Ceased GB201403630D0 (en) | 2014-02-28 | 2014-02-28 | Treatment of cystic fibrosis with alginate oligomers |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB201403630D0 (en) |
-
2014
- 2014-02-28 GB GB201403630A patent/GB201403630D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201803727B (en) | Treatment of fibrosis | |
| IL271181A (en) | Methods of treatment for cystic fibrosis | |
| IL250960A0 (en) | Cenicriviroc combination therapy for the treatment of fibrosis | |
| IL247515A0 (en) | Cenicriviroc for the treatment of fibrosis | |
| IL258002A (en) | Cenicriviroc combination therapy for the treatment of fibrosis | |
| IL252839A0 (en) | Treatment of pemphigus | |
| EP2968285A4 (en) | Compounds and methods for the treatment of cystic fibrosis | |
| SG11201506309SA (en) | Eye massager | |
| IL248856B (en) | New treatment | |
| IL254825A0 (en) | Methods of treatment with taselisib | |
| GB201416832D0 (en) | Methods of treatment | |
| IL253617A0 (en) | Cenicriviroc for the treatment of fibrosis | |
| IL251350A0 (en) | Treatment of rett syndrome | |
| EP3226864A4 (en) | Methods of treating fibrosis | |
| GB201412010D0 (en) | Treatment of hypertransaminasemia | |
| GB201721718D0 (en) | Treatment of cystic fibrosis | |
| GB201403630D0 (en) | Treatment of cystic fibrosis with alginate oligomers | |
| GB201407806D0 (en) | Treatment of fibrosis | |
| AU2014904206A0 (en) | Treatment of fibrosis | |
| HK1244424A1 (en) | Methods for the treatment of cystic fibrosis | |
| GB201409159D0 (en) | Prediction and treatment of progressive fibrosis | |
| GB201311713D0 (en) | Cystic fibrosis treatment | |
| HK1241278A1 (en) | Cenicriviroc combination therapy for the treatment of fibrosis | |
| GB201417719D0 (en) | New treatment | |
| GB201408384D0 (en) | New treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |